Health · 1 views

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccin…

Source Guardian AI Summary Updated 1h 53m ago

Story intelligence Beta

Freshness Fresh Updated 1h 53m ago

Confidence Limited Single-outlet story

Coverage Single outlet

Views 1 Community interest

Read time 1 min ~64 words

AI Summary

Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic. Moderna is seeking Food and Drug Administration (FDA) approval of its new shot , dubbed mFlusiva, as an option for peop…

Read full article on The Guardian

AI summaries can be wrong sometimes—always verify important details using the source article.